Candida auris: update to management guidance
- From:
- UK Health Security Agency
- Published
- 14 June 2023
- Last updated
- 2 April 2025 — See all updates
Detail of outcome
This consultation is now closed.
Feedback has been incorporated into the updated Candidozyma auris (formerly Candida auris): guidance for acute healthcare settings.
Original consultation
Summary
This consultation asks for feedback on the updated guidance for the laboratory investigation, management and infection prevention and control of Candida auris.
This consultation closesran atfrom
to
Consultation description
The UK Health Security Agency (UKHSA) has opened a consultation on the new edition of its guidance for the management of Candida auris, previously published by Public Health England. Updates are in-keeping with the latest evidence (see attached literature review). This guidance includes laboratory investigation, management, and infection prevention and control (IPC) measures.
This consultation is now closed.
Feedback has been incorporated into the updated Candidozyma auris (formerly Candida auris): guidance for acute healthcare settings.
Original consultation
Summary
This consultation asks for feedback on the updated guidance for the laboratory investigation, management and infection prevention and control of Candida auris.
This consultation closesran atfrom
to
Consultation description
The UK Health Security Agency (UKHSA) has opened a consultation on the new edition of its guidance for the management of Candida auris, previously published by Public Health England. Updates are in-keeping with the latest evidence (see attached literature review). This guidance includes laboratory investigation, management, and infection prevention and control (IPC) measures.
Consultation description
The UK Health Security Agency (UKHSA) has opened a consultation on the new edition of its guidance for the management of Candida auris, previously published by Public Health England. Updates are in-keeping with the latest evidence (see attached literature review). This guidance includes laboratory investigation, management, and infection prevention and control (IPC) measures.